Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pacira Pharm Inc (PCRX)

Pacira Pharm Inc (PCRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,035,319
  • Shares Outstanding, K 43,863
  • Annual Sales, $ 429,650 K
  • Annual Income, $ 145,520 K
  • 60-Month Beta 1.15
  • Price/Sales 6.86
  • Price/Cash Flow 30.12
  • Price/Book 4.71
Trade PCRX with:

Options Overview

Details
  • Implied Volatility 78.26%
  • Historical Volatility 38.79%
  • IV Percentile 96%
  • IV Rank 74.55%
  • IV High 90.59% on 03/18/20
  • IV Low 42.12% on 11/19/20
  • Put/Call Vol Ratio 0.10
  • Today's Volume 11
  • Volume Avg (30-Day) 117
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 14
  • Open Int (30-Day) 889

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.38
  • Number of Estimates 6
  • High Estimate 0.60
  • Low Estimate 0.27
  • Prior Year 0.33
  • Growth Rate Est. (year over year) +15.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
64.81 +8.89%
on 03/05/21
80.00 -11.79%
on 02/25/21
-5.21 (-6.88%)
since 02/08/21
3-Month
55.87 +26.31%
on 12/10/20
80.00 -11.79%
on 02/25/21
+9.33 (+15.24%)
since 12/08/20
52-Week
27.46 +156.99%
on 03/23/20
80.00 -11.79%
on 02/25/21
+30.45 (+75.90%)
since 03/06/20

Most Recent Stories

More News
Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference

Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2021 Barclays Global Healthcare Conference at 10:55 AM ET on Tuesday, March 9, 2021. Live audio of the virtual event...

PCRX : 70.57 (+1.98%)
Pacira's (PCRX) Q4 Earnings Top Estimates, Revenues Miss

Pacira's (PCRX) earnings in the fourth quarter of 2020 beat estimates while revenues miss the same. Exparel sales rise year over year.

PCRX : 70.57 (+1.98%)
CANF : 1.8200 (-1.09%)
RDUS : 20.48 (-4.61%)
OPHLF : 29.7000 (+0.71%)
Pacira (PCRX) Q4 Earnings Beat Estimates

Pacira (PCRX) delivered earnings and revenue surprises of 6.10% and -0.89%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

PCRX : 70.57 (+1.98%)
Pacira: 4Q Earnings Snapshot

PARSIPPANY, N.J. (AP) _ Pacira Pharmaceuticals Inc. (PCRX) on Thursday reported fourth-quarter net income of $14.5 million, after reporting a loss in the same period a year earlier.

PCRX : 70.57 (+1.98%)
Pacira BioSciences Reports Full-Year and Fourth Quarter 2020 Financial Results

-- Reports record full-year 2020 revenue of $429.6 million --

PCRX : 70.57 (+1.98%)
Pacira Biosciences, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 25, 2021 / Pacira Biosciences, Inc. (NASDAQ:PCRX) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 25, 2021...

PCRX : 70.57 (+1.98%)
Pacira to Report 2020 Financial Results on Thursday February 25, 2021

Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its fourth quarter and year ended December 31, 2020 financial results before the open of the U.S. markets on Thursday, February...

PCRX : 70.57 (+1.98%)
Pacira BioSciences Reports Preliminary Net Product Sales of $36.0 Million for January 2021

Pacira BioSciences, Inc. (Nasdaq: PCRX), the leading provider of innovative non-opioid pain management options, today reported preliminary unaudited net product sales of EXPAREL (bupivacaine liposome injectable...

PCRX : 70.57 (+1.98%)
PCRX Crosses Above Average Analyst Target

In recent trading, shares of Pacira BioSciences Inc have crossed above the average analyst 12-month target price of $73.00, changing hands for $74.00/share. When a stock reaches the target an analyst...

PCRX : 70.57 (+1.98%)
Pacira BioSciences Announces Equity Investment in GeneQuine Biotherapeutics

Pacira BioSciences, Inc. (Nasdaq: PCRX), the leading provider of innovative non-opioid pain management options, today announced that the company will lead an equity investment in GeneQuine Biotherapeutics...

PCRX : 70.57 (+1.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. Pacira Pharmaceuticals, Inc....

See More

Key Turning Points

3rd Resistance Point 74.52
2nd Resistance Point 72.72
1st Resistance Point 71.65
Last Price 70.57
1st Support Level 68.78
2nd Support Level 66.98
3rd Support Level 65.91

See More

52-Week High 80.00
Last Price 70.57
Fibonacci 61.8% 59.93
Fibonacci 50% 53.73
Fibonacci 38.2% 47.53
52-Week Low 27.46

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar